The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
1.2.3 Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)
1.3 Market by Application
1.3.1 Global Human Low-Pass Whole Genome Sequencing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Low-Pass Whole Genome Sequencing Market Perspective (2018-2029)
2.2 Human Low-Pass Whole Genome Sequencing Growth Trends by Region
2.2.1 Global Human Low-Pass Whole Genome Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Human Low-Pass Whole Genome Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Region (2024-2029)
2.3 Human Low-Pass Whole Genome Sequencing Market Dynamics
2.3.1 Human Low-Pass Whole Genome Sequencing Industry Trends
2.3.2 Human Low-Pass Whole Genome Sequencing Market Drivers
2.3.3 Human Low-Pass Whole Genome Sequencing Market Challenges
2.3.4 Human Low-Pass Whole Genome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Low-Pass Whole Genome Sequencing Players by Revenue
3.1.1 Global Top Human Low-Pass Whole Genome Sequencing Players by Revenue (2018-2023)
3.1.2 Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Human Low-Pass Whole Genome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Low-Pass Whole Genome Sequencing Revenue
3.4 Global Human Low-Pass Whole Genome Sequencing Market Concentration Ratio
3.4.1 Global Human Low-Pass Whole Genome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Low-Pass Whole Genome Sequencing Revenue in 2022
3.5 Human Low-Pass Whole Genome Sequencing Key Players Head office and Area Served
3.6 Key Players Human Low-Pass Whole Genome Sequencing Product Solution and Service
3.7 Date of Enter into Human Low-Pass Whole Genome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Low-Pass Whole Genome Sequencing Breakdown Data by Type
4.1 Global Human Low-Pass Whole Genome Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Type (2024-2029)
5 Human Low-Pass Whole Genome Sequencing Breakdown Data by Application
5.1 Global Human Low-Pass Whole Genome Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
6.2 North America Human Low-Pass Whole Genome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023)
6.4 North America Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
7.2 Europe Human Low-Pass Whole Genome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023)
7.4 Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
8.2 Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
9.2 Latin America Human Low-Pass Whole Genome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023)
9.4 Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
10.2 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BGI
11.1.1 BGI Company Detail
11.1.2 BGI Business Overview
11.1.3 BGI Human Low-Pass Whole Genome Sequencing Introduction
11.1.4 BGI Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.1.5 BGI Recent Development
11.2 Breda Genetics
11.2.1 Breda Genetics Company Detail
11.2.2 Breda Genetics Business Overview
11.2.3 Breda Genetics Human Low-Pass Whole Genome Sequencing Introduction
11.2.4 Breda Genetics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.2.5 Breda Genetics Recent Development
11.3 Azenta Life Sciences
11.3.1 Azenta Life Sciences Company Detail
11.3.2 Azenta Life Sciences Business Overview
11.3.3 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Introduction
11.3.4 Azenta Life Sciences Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.3.5 Azenta Life Sciences Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Psomagen
11.5.1 Psomagen Company Detail
11.5.2 Psomagen Business Overview
11.5.3 Psomagen Human Low-Pass Whole Genome Sequencing Introduction
11.5.4 Psomagen Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.5.5 Psomagen Recent Development
11.6 Healgen Scientific
11.6.1 Healgen Scientific Company Detail
11.6.2 Healgen Scientific Business Overview
11.6.3 Healgen Scientific Human Low-Pass Whole Genome Sequencing Introduction
11.6.4 Healgen Scientific Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.6.5 Healgen Scientific Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Detail
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Human Low-Pass Whole Genome Sequencing Introduction
11.7.4 Agilent Technologies Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.7.5 Agilent Technologies Recent Development
11.8 Macrogen
11.8.1 Macrogen Company Detail
11.8.2 Macrogen Business Overview
11.8.3 Macrogen Human Low-Pass Whole Genome Sequencing Introduction
11.8.4 Macrogen Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.8.5 Macrogen Recent Development
11.9 Veritas Genetics
11.9.1 Veritas Genetics Company Detail
11.9.2 Veritas Genetics Business Overview
11.9.3 Veritas Genetics Human Low-Pass Whole Genome Sequencing Introduction
11.9.4 Veritas Genetics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.9.5 Veritas Genetics Recent Development
11.10 Centogene
11.10.1 Centogene Company Detail
11.10.2 Centogene Business Overview
11.10.3 Centogene Human Low-Pass Whole Genome Sequencing Introduction
11.10.4 Centogene Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.10.5 Centogene Recent Development
11.11 Nebula Genomics
11.11.1 Nebula Genomics Company Detail
11.11.2 Nebula Genomics Business Overview
11.11.3 Nebula Genomics Human Low-Pass Whole Genome Sequencing Introduction
11.11.4 Nebula Genomics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.11.5 Nebula Genomics Recent Development
11.12 CD Genomics
11.12.1 CD Genomics Company Detail
11.12.2 CD Genomics Business Overview
11.12.3 CD Genomics Human Low-Pass Whole Genome Sequencing Introduction
11.12.4 CD Genomics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.12.5 CD Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details